Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Cervical Cancer

Free Subscription 01.05.2023 2 Ann Clin Lab Sci 1 Ann Med Surg (Lond) 1 Anticancer Res 1 Apoptosis 1 Appl Biochem Biotechnol 1 Artif Intell Med 2 Asian Pac J Cancer Prev 1 Aust J Prim Health 1 Biochem Biophys Res Commun 2 Biomed Res Int 1 BMC Cancer 1 BMC Health Serv Res 1 BMC Womens Health 1 BMJ Open 1 Cancer 1 Cancer Genomics Proteomics 1 Cent Eur J Public Health 1 Comput Biol Med 1 Curr Med Sci 1 Eur J Surg Oncol 1 Genes (Basel) 1 Gynecol Oncol 1 Gynecol Oncol Rep 1 Heliyon 2 Infect Agent Cancer 1 Int J Mol Sci 1 Int J Qual Health Care 1 J Family Med Prim Care 1 J Infect Dis 1 J Low Genit Tract Dis 1 J Obstet Gynaecol 1 J Oncol 1 J Surg Oncol 2 J Virol Methods 3 Medicina (Kaunas) 4 Medicine (Baltimore) 1 Methods Mol Biol 1 Micron 1 Microorganisms 1 Mol Med Rep 1 Nanomedicine 1 NASN Sch Nurse 1 Oncotarget 1 PLoS One 1 Pract Radiat Oncol 1 Res Sq 1 Rev Panam Salud Publica 1 Womens Health Rep (New Rochelle)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Clin Lab Sci

1. SONG G, Ren J, Li Y, Cui J, et al
   Interference with XPO1 Suppresses the Stemness and Radioresistance of CD44 Positive Cervical Cancer Cells via Binding with Rad21.
   Ann Clin Lab Sci. 2023;53:278-292.
   PubMed         Abstract available
   
   
2. CHEN Y, Ma Q, Sun N
   DDX49 Promotes Proliferation and Metastasis of Cervical Cancer by Regulation of AKT and Wnt/beta-Catenin Signalings.
   Ann Clin Lab Sci. 2023;53:271-277.
   PubMed         Abstract available
   
   

   
   Ann Med Surg (Lond)

3. ISLAM MR, Dhar PS, Akash S, Sharma R, et al
   Public concerns about cervical cancer: outbreak, types, risk factors, etiology, stages, symptoms, prevention, and treatment.
   Ann Med Surg (Lond). 2023;85:1334-1335.
   PubMed        
   
   

   
   Anticancer Res

4. MIYASAKA Y, Yoshimoto Y, Ando K, Murata K, et al
   CD8-positive Tumor-infiltrating Lymphocytes and Prognosis in Radiotherapy for Uterine Cervical Squamous Cell Carcinoma.
   Anticancer Res. 2023;43:2077-2084.
   PubMed         Abstract available
   
   

   
   Apoptosis

5. RANGA S, Yadav R, Chhabra R, Chauhan MB, et al
   Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives.
   Apoptosis. 2023 Apr 25:1-18. doi: 10.1007/s10495-023-01840.
   PubMed         Abstract available
   
   

   
   Appl Biochem Biotechnol

6. POLEBOYINA PK, Alagumuthu M, Pasha A, Ravinder D, et al
   Entrectinib a Plausible Inhibitor for Osteopontin (SPP1) in Cervical Cancer-Integrated Bioinformatic Approach.
   Appl Biochem Biotechnol. 2023 Apr 22. doi: 10.1007/s12010-023-04541.
   PubMed         Abstract available
   
   

   
   Artif Intell Med

7. JHA AK, Mithun S, Sherkhane UB, Jaiswar V, et al
   Systematic review and meta-analysis of prediction models used in cervical cancer.
   Artif Intell Med. 2023;139:102549.
   PubMed         Abstract available
   
   

   
   Asian Pac J Cancer Prev

8. AHMADLOO N, Heidarpourfard M, Najib FS, Shiravani Z, et al
   The Feasibility and Safety of Induction Chemotherapy Followed by Definitive Chemoradiation in Patients with Locally Advanced Cervical Cancer: A Single-Arm Phase II Clinical Trial.
   Asian Pac J Cancer Prev. 2023;24:1321-1330.
   PubMed         Abstract available
   
   
9. ROH S, Lee HY, Jun JS, Lee YS, et al
   Andersen's Behavioral Model to Identify Correlates of Cervical Cancer Knowledge among American Indian Women.
   Asian Pac J Cancer Prev. 2023;24:1151-1157.
   PubMed         Abstract available
   
   

   
   Aust J Prim Health

10. YU J, Kenkre J, Wallace S, Thomas S, et al
    Methodological reflections on the recruitment and engagement of people for cancer screening research in Wales.
    Aust J Prim Health. 2023;29:148-154.
    PubMed         Abstract available
    
    

    
    Biochem Biophys Res Commun

11. OGAWA M, Hashimoto K, Kitano S, Yamashita S, et al
    Estrogen induces genomic instability in high-risk HPV-infected cervix and promotes the carcinogenesis of cervical adenocarcinoma.
    Biochem Biophys Res Commun. 2023;659:80-90.
    PubMed         Abstract available
    
    

    
    Biomed Res Int

12. CHAUHAN NK, Singh K, Kumar A, Kolambakar SB, et al
    HDFCN: A Robust Hybrid Deep Network Based on Feature Concatenation for Cervical Cancer Diagnosis on WSI Pap Smear Slides.
    Biomed Res Int. 2023;2023:4214817.
    PubMed         Abstract available
    
    
13. SHITU BF, Atnafu DD, Agumas Y
    Public School Adolescents Had Increased Odds of Being Willing to Uptake HPV Vaccinations Owing to Sociodemographic and Healthcare Access Features in Bahir Dar City, Ethiopia.
    Biomed Res Int. 2023;2023:2663815.
    PubMed         Abstract available
    
    

    
    BMC Cancer

14. ZHANG HW, Zhong XM, Zhang ZH, Pang HW, et al
    Dose prediction of organs at risk in patients with cervical cancer receiving brachytherapy using needle insertion based on a neural network method.
    BMC Cancer. 2023;23:385.
    PubMed         Abstract available
    
    

    
    BMC Health Serv Res

15. BOLARINWA OA, Holt N
    Barriers to breast and cervical cancer screening uptake among Black, Asian, and Minority Ethnic women in the United Kingdom: evidence from a mixed-methods systematic review.
    BMC Health Serv Res. 2023;23:390.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

16. DUCHANGE N, Poiseuil M, Rollet Q, Piette C, et al
    How do women comply with cancer screenings? A study in four regions of France.
    BMC Womens Health. 2023;23:190.
    PubMed         Abstract available
    
    

    
    BMJ Open

17. DZOBO M, Dzinamarira T, Maluleke K, Jaya ZN, et al
    Mapping evidence on the acceptability of human papillomavirus self-sampling for cervical cancer screening among women in sub-Saharan Africa: a scoping review.
    BMJ Open. 2023;13:e062090.
    PubMed         Abstract available
    
    

    
    Cancer

18. SPENCER JC, Noel L, Shokar NK, Pignone MP, et al
    Understanding the role of access in Hispanic cancer screening disparities.
    Cancer. 2023;129:1569-1578.
    PubMed         Abstract available
    
    

    
    Cancer Genomics Proteomics

19. RUCKRIEGL S, Loris J, Wert K, Bauerschmitz G, et al
    Knockdown of G Protein-coupled Estrogen Receptor 1 (GPER1) Enhances Tumor-supportive Properties in Cervical Carcinoma Cells.
    Cancer Genomics Proteomics. 2023;20:281-297.
    PubMed         Abstract available
    
    

    
    Cent Eur J Public Health

20. GULIASHVILI G, Taboridze I, Mebonia N, Alibegashvili T, et al
    Evaluation of barriers to cervical cancer screening in Georgia.
    Cent Eur J Public Health. 2023;31:9-18.
    PubMed         Abstract available
    
    

    
    Comput Biol Med

21. XIN X, Jia-Yin Y, Jun-Yang H, Rui W, et al
    Comprehensive analysis of lncRNA-mRNA co-expression networks in HPV-driven cervical cancer reveals the pivotal function of LINC00511-PGK1 in tumorigenesis.
    Comput Biol Med. 2023;159:106943.
    PubMed         Abstract available
    
    

    
    Curr Med Sci

22. LI XY, Wen JY, Huang YH, Wang WW, et al
    Primary Treatment for Clinically Early Cervical Cancer with Lymph Node Metastasis: Radical Surgery or Radiation?
    Curr Med Sci. 2023 Apr 28. doi: 10.1007/s11596-023-2722.
    PubMed         Abstract available
    
    

    
    Eur J Surg Oncol

23. DAVIDESKO S, Meirovitz M, Shaco-Levy R, Wainstock T, et al
    Positive pathological margins after loop electrosurgical excision procedure - Management and outcome.
    Eur J Surg Oncol. 2023;49:1031-1036.
    PubMed         Abstract available
    
    

    
    Genes (Basel)

24. SEKARAN K, Varghese RP, Gopikrishnan M, Alsamman AM, et al
    Unraveling the Dysbiosis of Vaginal Microbiome to Understand Cervical Cancer Disease Etiology-An Explainable AI Approach.
    Genes (Basel). 2023;14:936.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

25. KIM SI, Nam SH, Hwangbo S, Kim Y, et al
    Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R).
    Gynecol Oncol. 2023;173:88-97.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol Rep

26. ADDLEY S, Persic M, Kirke R, Abdul S, et al
    Combined direct hysteroscopic and real-time ultrasound guidance facilitating safe insertion of intra-uterine brachytherapy applicator for locally advanced cervical cancer with significant endocervical stenosis: A novel collaborative approach.
    Gynecol Oncol Rep. 2023;47:101178.
    PubMed         Abstract available
    
    

    
    Heliyon

27. XIA WT, Qiu WR, Yu WK, Xu ZC, et al
    Identifying TME signatures for cervical cancer prognosis based on GEO and TCGA databases.
    Heliyon. 2023;9:e15096.
    PubMed         Abstract available
    
    

    
    Infect Agent Cancer

28. LIU M, Lu J, Zhi Y, Ruan Y, et al
    Microendoscopy in vivo for the pathological diagnosis of cervical precancerous lesions and early cervical cancer.
    Infect Agent Cancer. 2023;18:26.
    PubMed         Abstract available
    
    
29. DADIPOOR S, Alavi A, Kader Z, Kakhaki HES, et al
    Correction: Utilization of cervical cancer screening services and its associated factors in Iran: a case-control study.
    Infect Agent Cancer. 2023;18:25.
    PubMed        
    
    

    
    Int J Mol Sci

30. KORBECKI J, Bosiacki M, Barczak K, Lagocka R, et al
    Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive Cancers: Breast Cancer, Cervical Cancer, Endometrial Cancer, Ovarian Cancer and Prostate Cancer.
    Int J Mol Sci. 2023;24:7262.
    PubMed         Abstract available
    
    

    
    Int J Qual Health Care

31. KIM W, Chun S, Lee SA
    Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea.
    Int J Qual Health Care. 2023 Apr 25:mzad024. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Family Med Prim Care

32. DEY T, Mukerjee A, Rai B, Arora M, et al
    Early integration of palliative care in cervical cancer: Experiences from a pilot study.
    J Family Med Prim Care. 2023;12:366-370.
    PubMed         Abstract available
    
    

    
    J Infect Dis

33. LI Z, Winer RL, Ba S, Sy MP, et al
    Effect of Human Immunodeficiency Virus Infection on Human Papillomavirus Clearance among Women in Senegal, West Africa.
    J Infect Dis. 2022 Oct 31. pii: 6782258. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Low Genit Tract Dis

34. FIRTINA TUNCER S, Tuncer HA
    Cervical Cancer Screening in Women Aged Older Than 65 Years.
    J Low Genit Tract Dis. 2023 Apr 25. doi: 10.1097/LGT.0000000000000742.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol

35. ZHANG J, Chen J, Yang X, Han J, et al
    Novel risk prediction models, involving coagulation, thromboelastography, stress response, and immune function indicators, for deep vein thrombosis after radical resection of cervical cancer and ovarian cancer.
    J Obstet Gynaecol. 2023;43:2204162.
    PubMed         Abstract available
    
    

    
    J Oncol

36. XIANG S, Wei M, Zhao L, Lin A, et al
    Integrated Analyses of the Expression and Prognostic Value of EPHB6 in Cervical Cancer and Its Correlation with Immune Infiltrates.
    J Oncol. 2023;2023:2258906.
    PubMed         Abstract available
    
    

    
    J Surg Oncol

37. MUNIR MM, Woldesenbet S, Alaimo L, Moazzam Z, et al
    Mediators of county-level racial and economic privilege in cancer screening.
    J Surg Oncol. 2023;127:1212-1222.
    PubMed         Abstract available
    
    

    
    J Virol Methods

38. EFFAH K, Agbemafle I, Essel NO, Amuah JE, et al
    Comparison of the AmpFire and MA-6000 polymerase chain reaction platforms for high-risk human papillomavirus testing in cervical precancer screening.
    J Virol Methods. 2023;316:114709.
    PubMed         Abstract available
    
    
39. QIU D, Liu Y, Wang Z, Zhang Z, et al
    Precision and correlation of ED(50) and endpoint titer method in measuring HPV vaccine immunogenicity.
    J Virol Methods. 2023;316:114716.
    PubMed         Abstract available
    
    

    
    Medicina (Kaunas)

40. CIANCI S, Tarascio M, Arcieri M, La Verde M, et al
    Post Treatment Sexual Function and Quality of Life of Patients Affected by Cervical Cancer: A Systematic Review.
    Medicina (Kaunas). 2023;59:704.
    PubMed         Abstract available
    
    
41. DIMITROVA P, Vasileva-Slaveva M, Shivarov V, Hasan I, et al
    Infiltration by Intratumor and Stromal CD8 and CD68 in Cervical Cancer.
    Medicina (Kaunas). 2023;59:728.
    PubMed         Abstract available
    
    
42. STUOPELYTE R, Zukiene G, Breiviene R, Rudaitis V, et al
    Quality of Life in Cervical Cancer Survivors Treated with Concurrent Chemoradiotherapy.
    Medicina (Kaunas). 2023;59:777.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

43. YEON CHOI H, Park JW
    Survival outcomes of minimally invasive versus open radical hysterectomy in patients with early-stage IB1 to IIA2 cervical cancer: A single-center retrospective study.
    Medicine (Baltimore). 2023;102:e33702.
    PubMed         Abstract available
    
    
44. ISLA-ORTIZ D, Torres-Dominguez J, Perez-Peralta L, Jimenez-Barrera H, et al
    Insurance status and access to cervical cancer treatment in a specialized cancer center in Mexico.
    Medicine (Baltimore). 2023;102:e33655.
    PubMed         Abstract available
    
    
45. MAO P, Zhang C, Wang X, Yang H, et al
    Copious vaginal discharge finally diagnosed as cervical adenocarcinoma: A case report.
    Medicine (Baltimore). 2023;102:e33614.
    PubMed         Abstract available
    
    
46. LI LP, Rao DF, Chen XX, Qi XY, et al
    The impact of hospital-family integrated continuation nursing based on information technology on patients unhealthy mood, family function and sexual function after cervical cancer surgery.
    Medicine (Baltimore). 2023;102:e33504.
    PubMed         Abstract available
    
    

    
    Methods Mol Biol

47. GOMES D, Passarinha LA, Sousa A
    E6 Tagged Protein Production, Extraction, and Purification from Escherichia coli Lysate.
    Methods Mol Biol. 2023;2652:21-33.
    PubMed         Abstract available
    
    

    
    Micron

48. PIETA E
    Nanoscale insight into biochemical changes in cervical cancer cells exposed to adaptogenic drug.
    Micron. 2023;170:103462.
    PubMed         Abstract available
    
    

    
    Microorganisms

49. TEKA B, Yoshida-Court K, Firdawoke E, Chanyalew Z, et al
    Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women.
    Microorganisms. 2023;11:833.
    PubMed         Abstract available
    
    

    
    Mol Med Rep

50. ZANG Y, Zhao R, Wang T, Gao Y, et al
    Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation.
    Mol Med Rep. 2023;27:115.
    PubMed         Abstract available
    
    

    
    Nanomedicine

51. MAURY P, Mondini M, Chargari C, Darricau A, et al
    Clinical transfer of AGuIX(R)-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework.
    Nanomedicine. 2023 Apr 19:102676. doi: 10.1016/j.nano.2023.102676.
    PubMed         Abstract available
    
    

    
    NASN Sch Nurse

52. GORDON J, Bail J
    Cancer Prevention Begins in Middle School: The Personal Advantages of HPV Immunization in Males.
    NASN Sch Nurse. 2023;38:114-120.
    PubMed         Abstract available
    
    

    
    Oncotarget

53. HAN D, Wang J, Cheng G
    Retraction: LncRNA NEAT1 enhances the radio-resistance of cervical cancer via miR-193b-3p/CCND1 axis.
    Oncotarget. 2023;14:363.
    PubMed        
    
    

    
    PLoS One

54. LIVESEY M, Rossouw SC, Blignaut R, Christoffels A, et al
    Transforming RNA-Seq gene expression to track cancer progression in the multi-stage early to advanced-stage cancer development.
    PLoS One. 2023;18:e0284458.
    PubMed         Abstract available
    
    

    
    Pract Radiat Oncol

55. BROWER JV, Bradley KA, Russo AL
    Management of Radiographically Positive Pelvic and/or Para-aortic Lymph Nodes During Primary Chemoradiation Therapy for Cervix Cancer.
    Pract Radiat Oncol. 2023;13:246-250.
    PubMed        
    
    

    
    Res Sq

56. ENDALAMAW A, Alganeh H, Azage M, Atnafu A, et al
    Improving cervical cancer continuum of care towards elimination in Ethiopia: a scoping review.
    Res Sq. 2023 Apr 14:rs.3.rs-2791526. doi: 10.21203/rs.3.rs-2791526.
    PubMed         Abstract available
    
    

    
    Rev Panam Salud Publica

57. 
    [Synthesis of evidence and recommendations: guidelines for cervical cancer screening, detection, and treatmentSintese de evidencias e recomendacoes: diretrizes para rastreamento, deteccao e tratamento do cancer do colo do utero].
    Rev Panam Salud Publica. 2023;47:e72.
    PubMed         Abstract available
    
    

    
    Womens Health Rep (New Rochelle)

58. JENSEN B, Khan H, Layeequr Rahman R
    Sociodemographic Determinants in Cervical Cancer Screening Among the Underserved West Texas Women.
    Womens Health Rep (New Rochelle). 2023;4:191-201.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: